GIST trial
Credit: OHSU/Kristyna Wentz-Graff
Michael Heinrich, M.D., at OHSU, Jan. 8, 2020, wears a "Slay GIST" hat during an appointment with a patient. Heinrich consulted with the company that developed a drug treating a rare stomach cancer, GIST. The drug was recently approved by the FDA. (OHSU/Kristyna Wentz-Graff)